ArticleJournal of imaging informatics in medicine2026
Classification of Renal Lesions by Leveraging Hybrid Features from CT Images Using Machine Learning Techniques.
Article in Journal of imaging informatics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Renal cancer is amid the several reasons of increasing mortality rates globally, which can be reduced by early detection and diagnosis. The classification of lesions is based mostly on their characteristics, which include varied shape and texture properties. Computed tomography (CT) imaging is a regularly used imaging modality for study of the renal soft tissues. Furthermore, a radiologist's ability to assess a corpus of CT images is limited, which can lead to misdiagnosis of kidney lesions, which might lead to cancer progression or unnecessary chemotherapy. To address these challenges, this study presents a machine learning technique based on a novel feature vector for the automated classification of renal lesions using a multi-model texture-based feature extraction. The proposed feature vector could serve as an integral component in improving the accuracy of a computer aided diagnosis (CAD) system for identifying the texture of renal lesion and can assist physicians in order to provide more precise lesion interpretation. In this work, the authors employed different texture models for the analysis of CT scans, in order to classify benign and malignant kidney lesions. Texture analysis is performed using features such as first-order statistics (FoS), spatial gray level co-occurrence matrix (SGLCM), Fourier power spectrum (FPS), statistical feature matrix (SFM), Law's texture energy measures (TEM), gray level difference statistics (GLDS), fractal, and neighborhood gray tone difference matrix (NGTDM). Multiple texture models were utilized to quantify the renal texture patterns, which used image texture analysis on a selected region of interest (ROI) from the renal lesions. In addition, dimensionality reduction is employed to discover the most discriminative features for categorization of benign and malignant lesions, and a unique feature vector based on correlation-based feature selection, information gain, and gain ratio is proposed. Different machine learning-based classifiers were employed to test the performance of the proposed features, out of which the random forest (RF) model outperforms all other techniques to distinguish benign from malignant tumors in terms of distinct performance evaluation metrics. The final feature set is evaluated using various machine learning classifiers, with the RF model achieving the highest performance. The proposed system is validated on a dataset of 50 subjects, achieving a classification accuracy of 95.8%, outperforming other conventional models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.